Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-27T14:52:50.532Z Has data issue: false hasContentIssue false

Adverse Reaction to Nicotine Gum in a Poor Metaboliser

Published online by Cambridge University Press:  21 February 2012

Noorzurani Md Haris Robson*
Affiliation:
Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Malaysia. noorzurani@hotmail.com
Alyson J. Bond
Affiliation:
King's College London, National Addiction Centre, Institute of Psychiatry, London United Kingdom.
Kim Wolff
Affiliation:
King's College London, National Addiction Centre, Institute of Psychiatry, London United Kingdom.
*
*Address for correspondence: Dr Noorzurani Md Haris Robson, Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia.

Abstract

Purpose: To report a case of adverse reaction to nicotine gum in a Chinese female with poor nicotine metabolic status after chewing a piece of 2 mg nicotine gum (NG). Background: NG is prescribed in smoking cessation programs to help individuals stop smoking. In smoking cessation treatment, the dose of NG should control withdrawal symptoms but avoid adverse effects. Case results: We describe a case of an adverse reaction following the administration of 2 mg NG to a female Chinese subject. This study compared a single dose of 2 mg NG with a single low dose cigarette (0.7 mg nicotine). Blood (5mL) was collected at baseline and 2h post exposure to NG. Blood pressure and pulse rate were also recorded. Nicotine metabolic rate was determined by calculation of the ratio of plasma cotinine (ng/mL)/plasma nicotine (ng/mL). The subject developed nausea and severe vomiting with raised blood pressure and pulse rate following administration of NG. The ratio of plasma cotinine/nicotine was 0.4 indicative of poor nicotine metabolic rate. Exposure to nicotine using the subject's normal cigarette did not produce similar adverse effects. Conclusion: NG may be associated with adverse reactions in smokers with low nicotine metabolic rate. Physicians in smoking cessation programs should be aware that some individuals may not tolerate this form of pharmacological treatment.

Type
Case Report
Copyright
Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)